CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy-Reference-Cited by-同舟云学术

CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy

Published:2022-08-31 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Li Xiaofei¹,Lu Mingjie¹,Yuan Manman²,Ye Jing²,Zhang Wei¹,Xu Lingyan¹,Wu Xiaohan¹,Hui Bingqing¹,Yang Yuchen¹,Wei Bin³,Guo Ciliang⁴,Wei Min⁴,Dong Jie⁴,Wu Xingxin²,Gu Yanhong¹

Affiliation:

1. Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2. State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China

3. Department of Oncology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, China

4. Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China

Funder

National Natural Science Foundation of China

Jiangsu Province Key Medical Talents

Fundamental Research Funds for the Central Universities

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2118210

Reference51 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy

3. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

5. A subset of patients with MSS/MSI‑low‑colorectal cancer showed increased CD8(+) TILs together with up‑regulated IFN‑γ

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth;Biomedicine & Pharmacotherapy;2024-10

2. Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10/CXCR3 to boost antitumor immunity;Cell Proliferation;2024-09

3. p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death;Molecular Therapy: Oncology;2024-09

4. CXCL12 inhibited T lymphocyte infiltration and promoted breast cancer metastasis;2024-08-27

5. Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions;Clinical and Experimental Medicine;2024-08-14